The data presented here provide several insights into the molecular mechanisms behind KC transfection resistance, the consequences of which include suppression of IFN responses in genetically corrected KCs, and provides a simple way, with the use of JAK inhibition, to circumvent these issues. Here, IFNA1 is linked to dry eye syndrome.